Advanced Enzyme Technologies Limited — Others, 30-07-2025: Shareholders meeting

Advanced Enzyme Technologies Limited held its 36th Annual General Meeting via video conference. Key items considered included the adoption of the audited financial statements for the financial year ended March 31, 2025 (both standalone and consolidated). Shareholders also reviewed a proposal to declare a final dividend of ₹1.20 per equity share. Other significant resolutions covered the re-appointment of Mr. Mukund Kabra as a Director, the appointment of a Secretarial Auditor, and the approval of related party transactions with its subsidiary, JC Biotech Private Limited. Voting results from the e-voting process will be declared shortly.